162 related articles for article (PubMed ID: 6233614)
21. Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.
Muraguchi A; Butler JL; Kehrl JH; Fauci AS
J Exp Med; 1983 Feb; 157(2):530-46. PubMed ID: 6401797
[TBL] [Abstract][Full Text] [Related]
22. Regulation of hapten-specific T and B cell responses by suppressor cells.
Hausman PB; Sherr DH; Dorf ME
Concepts Immunopathol; 1986; 3():38-60. PubMed ID: 2954643
[TBL] [Abstract][Full Text] [Related]
23. Internal complementarities in the immune system: regulation of the expression of helper T-cell idiotypes.
Martinez C; Pereira P; Bernabé R; Bandeira A; Larsson EL; Cazenave PA; Coutinho A
Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4520-3. PubMed ID: 6235521
[TBL] [Abstract][Full Text] [Related]
24. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
25. Biologic activity of an idiotype-bearing suppressor T cell factor produced by a long-term T cell hybridoma.
Takaoki M; Sy MS; Whitaker B; Nepom J; Finberg R; Germain RN; Nisonoff A; Benacerraf B; Greene MI
J Immunol; 1982 Jan; 128(1):49-53. PubMed ID: 6459378
[TBL] [Abstract][Full Text] [Related]
26. Effects of mu-specific antibodies on B cell growth and maturation.
Leanderson T; Forni L
Eur J Immunol; 1984 Nov; 14(11):1016-21. PubMed ID: 6437843
[TBL] [Abstract][Full Text] [Related]
27. Comparison of T suppressor factors from tumour-bearing mice and mice immunized with a monoclonal anti-idiotypic antibody.
Greer JM; Halliday WJ
Cancer Immunol Immunother; 1990; 31(3):151-6. PubMed ID: 2110863
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants.
George AJ; McBride HM; Glennie MJ; Smith LJ; Stevenson FK
Hybridoma; 1991 Apr; 10(2):219-27. PubMed ID: 1908435
[TBL] [Abstract][Full Text] [Related]
29. Activation of mouse lymphocytes by anti-immunoglobulin. IV. Stimulation with soluble heterologous anti-delta antibodies.
Sieckmann DG; Finkelman FD; Thompson CB; Scher I
Cell Immunol; 1984 Apr; 85(1):1-14. PubMed ID: 6424947
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
Sacks DL; Scott PA; Asofsky R; Sher FA
J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
[TBL] [Abstract][Full Text] [Related]
31. Alteration of the B cell surface phenotype, immune response to phosphocholine and the B cell repertoire in M167 mu plus kappa transgenic mice.
Kenny JJ; Finkelman F; Macchiarini F; Kopp WC; Storb U; Longo DL
J Immunol; 1989 Jun; 142(12):4466-74. PubMed ID: 2498429
[TBL] [Abstract][Full Text] [Related]
32. B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain.
Brombacher F; Köhler G; Eibel H
J Exp Med; 1991 Dec; 174(6):1335-46. PubMed ID: 1744576
[TBL] [Abstract][Full Text] [Related]
33. Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco AL; Raveche ES; Asofsky R; Paul WE
J Exp Med; 1982 May; 155(5):1523-36. PubMed ID: 6802927
[TBL] [Abstract][Full Text] [Related]
34. Antigen- and receptor-driven regulatory mechanisms. VIII. Suppression of idiotype-negative, p-azobenzenearsonate-specific T cells results from the interaction of an anti-idiotypic second-order T suppressor cell with a cross-reactive-idiotype-positive, p-azobenzenearsonate-primed T cell target.
Sy MS; Nisonoff A; Germain RN; Benacerraf B; Greene MI
J Exp Med; 1981 Jun; 153(6):1415-25. PubMed ID: 6454748
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
[TBL] [Abstract][Full Text] [Related]
36. Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells.
Chen U; Scheuermann RH; Wirth T; Gerster T; Roeder RG; Harshman K; Berger C
Nucleic Acids Res; 1991 Nov; 19(21):5981-9. PubMed ID: 1658749
[TBL] [Abstract][Full Text] [Related]
37. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo.
Hayglass KT; Naides SJ; Scott CF; Benacerraf B; Sy MS
J Immunol; 1986 Feb; 136(3):823-9. PubMed ID: 2416835
[TBL] [Abstract][Full Text] [Related]
38. The expression of idiotypic determinants on suppressor T cells is independent of T cell Igh genotype.
Usui M; Ju ST; Dorf ME
J Mol Cell Immunol; 1984; 1(5):293-304. PubMed ID: 6242860
[TBL] [Abstract][Full Text] [Related]
39. Murine interstitial nephritis. VII. Suppression of renal injury after treatment with soluble suppressor factor TsF1.
Neilson EG; Kelly CJ; Clayman MD; Hines WH; Haverty T; Sun MJ; Blanchard N
J Immunol; 1987 Sep; 139(5):1518-24. PubMed ID: 2957427
[TBL] [Abstract][Full Text] [Related]
40. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. II. Anti-mu treatment affects the initiation and recruitment of T cells.
Ron Y; De Baetselier P; Tzehoval E; Gordon J; Feldman M; Segal S
Eur J Immunol; 1983 Feb; 13(2):167-71. PubMed ID: 6403358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
